Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York; Department of Otolaryngology and Head and Neck Surgery, Columbia University Irving Medical Center, New York, New York.
Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Cell Mol Gastroenterol Hepatol. 2024;18(5):101387. doi: 10.1016/j.jcmgh.2024.101387. Epub 2024 Aug 5.
BACKGROUND & AIMS: Pancreatic ductal adenocarcinoma can develop from precursor lesions, including pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasm (IPMN). Previous studies indicated that loss of Acvr1b accelerates the Kras-mediated development of papillary IPMN in the mouse pancreas; however, the cell type predominantly affected by these genetic changes remains unclear.
We investigated the contribution of cellular origin by inducing IPMN associated mutations (KRAS expression and Acvr1b loss) specifically in acinar (Ptf1a;Kras;Acvr1b mice) or ductal (Sox9CreER;Kras;Acvr1b mice) cells in mice. We then performed magnetic resonance imaging and a thorough histopathologic analysis of their pancreatic tissues.
The loss of Acvr1b increased the development of pancreatic intraepithelial neoplasia and IPMN-like lesions when either acinar or ductal cells expressed a Kras mutation. Magnetic resonance imaging, immunohistochemistry, and histology revealed large IPMN-like lesions in these mice that exhibited features of flat, gastric epithelium. In addition, cyst formation in both mouse models was accompanied by chronic pancreatitis. Experimental acute pancreatitis accelerated the development of large mucinous cysts and pancreatic intraepithelial neoplasia when acinar, but not ductal, cells expressed mutant Kras and lost Acvr1b.
These findings indicate that loss of Acvr1b in the presence of the Kras oncogene promotes the development of large and small precancerous lesions from both ductal and acinar cells. However, the IPMN-like phenotype was not equivalent to that observed when these mutations were made in all pancreatic cells during development. Our study underscores the significance of the cellular context in the initiation and progression of precursor lesions from exocrine cells.
胰腺导管腺癌可由前体病变发展而来,包括胰腺上皮内瘤变和导管内乳头状黏液性肿瘤(IPMN)。先前的研究表明,Acvr1b 的缺失加速了小鼠胰腺中 Kras 介导的乳头状 IPMN 的发展;然而,这些遗传变化主要影响的细胞类型仍不清楚。
我们通过在小鼠的腺泡(Ptf1a;Kras;Acvr1b 小鼠)或导管(Sox9CreER;Kras;Acvr1b 小鼠)细胞中特异性诱导与 IPMN 相关的突变(Kras 表达和 Acvr1b 缺失),研究了细胞起源的贡献。然后,我们对其胰腺组织进行了磁共振成像和全面的组织病理学分析。
当腺泡或导管细胞表达 Kras 突变时,Acvr1b 的缺失增加了胰腺上皮内瘤变和 IPMN 样病变的发生。磁共振成像、免疫组织化学和组织学显示,这些小鼠中存在大的 IPMN 样病变,表现为扁平、胃上皮样特征。此外,两种小鼠模型中的囊肿形成均伴有慢性胰腺炎。当腺泡而非导管细胞表达突变型 Kras 并缺失 Acvr1b 时,实验性急性胰腺炎加速了大黏液性囊肿和胰腺上皮内瘤变的发展。
这些发现表明,在 Kras 癌基因存在的情况下,Acvr1b 的缺失促进了导管和腺泡细胞前体病变的大、小肿瘤的发生。然而,与在发育过程中使所有胰腺细胞发生这些突变时观察到的 IPMN 样表型并不相同。我们的研究强调了细胞背景在起始和进展过程中对前体病变的重要性。